May 28, 2025, 13:05
Antiphospholipid Syndrome (APS) Management: A 2024 Update and Review
Rheuma Doc – shared a post on X:
“A Nice Summary of Recommendations for the treatment of Antiphospholipid Syndrome (APS) [F.Bashal et al]․
‘Clinical Advances in APS: Evidence-Based Guidance for Rheumatologists and Hematologists.'”
Title: Thrombosis in Rheumatological Diseases
Author: Fozya Bashal
The article is quite interesting and has been featured on Hemostasis Today.
-
Aug 3, 2026, 16:01Your First Steps After an ITP Diagnosis – ITP Support Association
-
Aug 3, 2026, 15:33Christina Crossette-Thambiah: Scientific Excellence and Mentorship at ISTH 2026
-
Aug 3, 2026, 15:22Connie Montgomery: Why Global Support is Essential for the HFA Black Voices Initiative
-
Aug 3, 2026, 15:18Ifeanyichukwu Ifechidere: The DOAC Monitoring Masterclass
-
Aug 3, 2026, 15:02David McIntosh: UK Plasma Action – a Founder’s Reflections
-
Aug 3, 2026, 14:49Ney Carter Borges: Targeting the Gut Microbiome to Prevent Atrial Fibrillation
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients